Insider Transactions in Q4 2025 at Amgen Inc (AMGN)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2025
|
Nancy A. Grygiel SVP & CCO |
SELL
Open market or private sale
|
Direct |
3,139
-17.84%
|
$1,057,843
$337.26 P/Share
|
|
Nov 20
2025
|
Nancy A. Grygiel SVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,139
+15.14%
|
$533,630
$170.03 P/Share
|
|
Nov 12
2025
|
Murdo Gordon EVP, Global Commercial Ops |
SELL
Open market or private sale
|
Direct |
6,879
-14.1%
|
$2,311,344
$336.83 P/Share
|
|
Nov 12
2025
|
Rachna Khosla SVP, Business Development |
SELL
Open market or private sale
|
Direct |
890
-11.16%
|
$299,040
$336.24 P/Share
|
|
Nov 12
2025
|
David M Reese EVP & Chief Technology Officer |
SELL
Bona fide gift
|
Direct |
309
-0.86%
|
-
|
|
Nov 11
2025
|
David M Reese EVP & Chief Technology Officer |
SELL
Bona fide gift
|
Direct |
6,490
-15.34%
|
-
|
|
Nov 07
2025
|
Michael V Drake Director |
BUY
Grant, award, or other acquisition
|
Direct |
218
+4.21%
|
-
|
|
Nov 07
2025
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
265
+2.19%
|
-
|
|
Nov 07
2025
|
Omar Ishrak Director |
BUY
Grant, award, or other acquisition
|
Direct |
218
+3.24%
|
-
|
|
Nov 05
2025
|
Matthew C. Busch VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-4.38%
|
$59,792
$296.7 P/Share
|
|
Nov 05
2025
|
Rachna Khosla SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
226
-2.76%
|
$66,896
$296.7 P/Share
|